Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Receivables (2016 - 2025)

Historic Receivables for Cryo Cell International (CCEL) over the last 16 years, with Q3 2025 value amounting to $7.7 million.

  • Cryo Cell International's Receivables rose 44.08% to $7.7 million in Q3 2025 from the same period last year, while for Aug 2025 it was $7.7 million, marking a year-over-year increase of 44.08%. This contributed to the annual value of $8.1 million for FY2024, which is 1117.04% up from last year.
  • Per Cryo Cell International's latest filing, its Receivables stood at $7.7 million for Q3 2025, which was up 44.08% from $7.7 million recorded in Q2 2025.
  • Cryo Cell International's 5-year Receivables high stood at $8.1 million for Q4 2024, and its period low was $5.7 million during Q1 2022.
  • Over the past 5 years, Cryo Cell International's median Receivables value was $7.2 million (recorded in 2023), while the average stood at $6.9 million.
  • Its Receivables has fluctuated over the past 5 years, first tumbled by 1473.55% in 2021, then soared by 2819.05% in 2023.
  • Quarter analysis of 5 years shows Cryo Cell International's Receivables stood at $5.8 million in 2021, then increased by 15.04% to $6.7 million in 2022, then grew by 9.2% to $7.3 million in 2023, then increased by 11.17% to $8.1 million in 2024, then dropped by 5.19% to $7.7 million in 2025.
  • Its Receivables was $7.7 million in Q3 2025, compared to $7.7 million in Q2 2025 and $8.0 million in Q1 2025.